分子量: 1379.668 Da / 分子数: 1 / 由来タイプ: 合成 詳細: THIS SEQUENCE OCCURS NATURALLY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 参照: UniProt: P12488
Has protein modification
Y
-
実験情報
-
実験
実験
手法: 溶液NMR
NMR実験
タイプ: 2D NOESY
NMR実験の詳細
Text: This structure was determined using standard 2D homonuclear techniques. NOESY experiments with mixing times from 80ms to 800ms were reccorded in order to define the best conditions avoiding spin diffusion.
-
試料調製
詳細
内容: 2mM and 4mM peptide ; 500 ul DMSO-D6 / 溶媒系: DMSO-D6
試料状態
圧: ambient / 温度: 298 K
結晶化
*PLUS
手法: other / 詳細: NMR
-
NMR測定
放射
プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M
放射波長
相対比: 1
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Bruker AVANCE
Bruker
AVANCE
400
1
Bruker AVANCE
Bruker
AVANCE
600
2
-
解析
NMR software
名称
バージョン
開発者
分類
XwinNMR
2.6
BrukerbrmH
collection
XwinNMR
2.6
BrukerbrmH
解析
XEASY
Bartels C.,Xia T. , Billeter M., Guentert P. and Wthrich K. J. Biomolecular NMR 5, 1-10
データ解析
DYANA
1.5
Guentert P., Mumenthaler C.and Wuethrich K., (1997) J. Mol. Biol. 273, 283-298
精密化
Discover
3
MolecularSImulationInc., SanDiego
精密化
精密化
手法: torsion angle dynamics energy minimisation / ソフトェア番号: 1 詳細: 50 initial random strucutres were produced using simulated annealing in DYANA software.Refinement was done with 500 steps restrained minimization , 35ps MD in vacuo at 300K for equilibration ...詳細: 50 initial random strucutres were produced using simulated annealing in DYANA software.Refinement was done with 500 steps restrained minimization , 35ps MD in vacuo at 300K for equilibration and 200ps MD under NMR restraints and 750 steps conjugeted gradient EM using DISCOVER module of MSI software.
代表構造
選択基準: minimized average structure
NMRアンサンブル
コンフォーマー選択の基準: target function / 計算したコンフォーマーの数: 50 / 登録したコンフォーマーの数: 1